logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Federica Morano

university of pisa
H指数:37
被引数:6,333

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trials

原发肿瘤侧别及负超选择对RAS野生型转移性结直肠癌患者抗EGFR为基础维持疗法的影响：两项随机临床试验的个体患者数据合并分析

British Journal of Cancer
IF6.8
2025-08-280
OAAI
Alexej Ballhausen; Federica Morano; Arndt Stahler; Sara Lonardi; Andreas Jay Kind; Chiara Cremolini; Susanna Swoboda; Giovanni Randon; David Horst; Michele Prisciandaro; Annabel Helga Sophie Alig; Chiara Carlotta Pircher; Armin Jarosch; Paola Andena; Annika Kurreck; Anna Alessandra Chiaramonte; Sebastian Stintzing; Filippo Pietrantonio; Dominik Paul Modest; Alessandra Raimondi
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO

转移性结直肠癌一线治疗中疾病进展的风险，以指导疾病再评估——AIO和GONO对11项试验的分析

Annals of Oncology
IF65.4
2025-08-190
OAAI
M.M. Germani; V. Heinemann; D. Rossini; L. Fischer von Weikersthal; F. Pietrantonio; K. Heinrich; A. Stahler; S. Lonardi; F. Kaiser; T. Decker; L. Salvatore; L. Weiss; F. Morano; M. Fuchs; F. Bergamo; C. Antoniotti; G. Masi; S. Stintzing; P. Frumento; C. Cremolini; D.P. Modest
Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma

II期PANDORA试验的设计与原理：晚期默克尔细胞癌的一线化疗免疫疗法

Future Oncology
IF2.6
2025-06-120
OA
Simone Oldani; Natalie Prinzi; Federica Morano; Sara Cingarlini; Anna Maria Di Giacomo; Monica Niger; Michele Prisciandaro; Alessandra Raimondi; Giovanni Randon; Chiara Carlotta Pircher; Michele Borghesani; Monica Valente; Elvira Rostanzo; Massimo Milione; Giovanna Sabella; Tommaso Cascella; Filippo Ghelardi; Carolina Sciortino; Eleonora Gusmaroli; Vincenzo Nasca; Filippo de Braud; Filippo Pietrantonio; Sara Pusceddu
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial
BMC CANCER
IF3.4
2025-04-080
OAAI
Nasca, Vincenzo; Bergamo, Francesca; Foltran, Luisa; Antonuzzo, Lorenzo; Bencardino, Katia; Dell'Aquila, Emanuela; Corallo, Salvatore; Spallanzani, Andrea; Brunetti, Oronzo; Spada, Daniele; Tamberi, Stefano; Cella, Chiara Alessandra; Avallone, Antonio; Fornaro, Lorenzo; Di Donato, Samantha; Strippoli, Antonia; Puccini, Alberto; Tamburini, Emiliano; Palermo, Federica; Morano, Federica; Pietrantonio, Filippo; Raimondi, Alessandra
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

曲美木单抗和度伐利尤单抗作为微卫星不稳定性高、可切除的胃或胃食管结合部腺癌患者的新辅助治疗或非手术治疗策略：GONO开展的INFINITY研究

ANNALS OF ONCOLOGY
IF65.4
2025-03-018
PRE
Raimondi, A.; Lonardi, S.; Murgioni, S.; Cardellino, G. G.; Tamberi, S.; Strippoli, A.; Palermo, F.; De Manzoni, G.; Bencivenga, M.; Bittoni, A.; Chiodoni, C.; Lorenzini, D.; Todoerti, K.; Manca, P.; Sangaletti, S.; Prisciandaro, M.; Randon, G.; Nichetti, F.; Bergamo, F.; Brich, S.; Belfiore, A.; Bertolotti, A.; Stetco, D.; Guidi, A.; Torelli, T.; Vingiani, A.; Joshi, R. P.; Khoshdeli, M.; Beaubier, N.; Stumpe, M. C.; Nappo, F.; Leone, A. G.; Pircher, C. C.; Leoncini, G.; Sabella, G.; Farulla, L. Airo'; Alessi, A.; Morano, F.; Martinetti, A.; Niger, M.; Fassan, M.; Di Maio, M.; Kaneva, K.; Milione, M.; Nimeiri, H.; Sposito, C.; Agnelli, L.; Mazzaferro, V.; Di Bartolomeo, M.; Pietrantonio, F.
Evaluation of risk of disease progression in first-line therapy of unresected metastatic colorectal cancer to guide intervals of radiological assessment: An analysis of eleven randomized trials by AIO and GONO

评估不可切除的转移性结直肠癌一线治疗中疾病进展风险的评估，以指导放射学评估的间隔：AIO和GONO进行的十一项随机试验的分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Germani, M. M.; Heinemann, V.; Rossini, D.; von Weikersthal, L. Fischer; Morano, F.; Heinrich, K.; Stahler, A.; Bergamo, F.; Kaiser, F.; Decker, T.; Salvatore, L.; Weiss, L.; Russo, A.; Fuchs, M.; Prete, A. A.; Antoniotti, C.; Masi, G.; Stintzing, S.; Cremolini, C.; Modest, D. P.
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-09-010
PRE
Nasca, Vincenzo; Prinzi, Natalie; Coppa, Jorgelina; Prisciandaro, Michele; Oldani, Simone; Ghelardi, Filippo; Conca, Elena; Capone, Iolanda; Busico, Adele; Perrone, Federica; Tamborini, Elena; Sabella, Giovanna; Greco, Giorgio; Greco, Francesca Gabriella; Tafuto, Salvatore; Procopio, Giuseppe; Morano, Federica; Niger, Monica; Maccauro, Marco; Milione, Massimo; de Braud, Filippo; Pietrantonio, Filippo; Pusceddu, Sara
mRNA profiling as a biomarker of prognosis and response to first-line treatment in metastatic colorectal cancer: Discovery and validation of a gene expression signature in three randomized trials

mRNA表达谱作为转移性结直肠癌预后及一线治疗反应的生物标志物：基于三项随机试验的基因表达谱发现与验证

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Germani, M. M.; Heinemann, V.; Pietrantonio, F.; von W, L. Fischer; Na, I-K.; Hoppe, B.; Jarosch, A.; Lonardi, S.; Morano, F.; Medico, E.; Karthaus, M.; Fruehauf, S.; Graeven, U.; Decker, T.; Kaiser, F.; Stintzing, S.; Stahler, A.; Modest, D. P.
Multicentre, multi-cohort, single-arm phase II trial of tremelimumab and durvalumab as neoadjuvant or definitive treatment of patients (pts) with microsatellite instabilityhigh (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC): The INFINITY study
ANNALS OF ONCOLOGY
IF65.4
2024-06-010
PRE
Raimondi, A.; Lonardi, S.; Murgioni, S.; Cardellino, G.; Passardi, A.; Demanzoni, G.; Strippoli, A.; Palermo, F.; Prisciandaro, M.; Bergamo, F.; Garattini, S. K.; Frassineti, G. L.; Bencivenga, M.; Randon, G.; Leone, A. G.; Nappo, F.; Mazzaferro, V.; Sposito, C. F.; Morano, F.; Pietrantonio, F.
Adjuvant trastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: The TRINITY trial
ANNALS OF ONCOLOGY
IF65.4
2024-06-011
PRE
Nasca, V.; Raimondi, A.; Palermo, F.; Morano, F.; Bergamo, F.; Foltran, L.; Spallanzani, A.; Brunetti, O.; Spada, D.; Tamberi, S.; Antonuzzo, L.; Cella, C. A.; Avallone, A.; Bencardino, K.; Fornaro, L.; Di Donato, S.; Strippoli, A.; Puccini, A.; Tamburini, E.; Pietrantonio, F.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study (vol 24, 436, 2024)
BMC CANCER
IF3.4
2024-05-060
OAAI
Niger, Monica; Nichetti, Federico; Fornaro, Lorenzo; Pircher, Chiara; Morano, Federica; Palermo, Federica; Rimassa, Lorenza; Pressiani, Tiziana; Berardi, Rossana; Gardini, Andrea Casadei; Sperti, Elisa; Salvatore, Lisa; Melisi, Davide; Bergamo, Francesca; Siena, Salvatore; Mosconi, Stefania; Longarini, Rafaella; Arcangeli, Giuseppina; Corallo, Salvatore; Delliponti, Laura; Tamberi, Stefano; Fea, Elena; Brandi, Giovanni; Rapposelli, Ilario Giovanni; Salati, Massimiliano; Baili, Paolo; Miceli, Rosalba; Ljevar, Silva; Cavallo, Ilaria; Sottotetti, Elisa; Martinetti, Antonia; Busset, Michele Droz Dit; Sposito, Carlo; Di Bartolomeo, Maria; Pietrantonio, Filippo; de Braud, Filippo; Mazzaferro, Vincenzo
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials

性别对局部晚期微卫星不稳定性高的胃或胃食管交界癌的预后和预测影响: 一项随机临床试验的个体患者数据汇总分析

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-05-010
PRE
Raimondi, Alessandra; Kim, Young Woo; Kang, Won Ki; Langley, Ruth E.; Choi, Yoon Young; Kim, Kyoung-Mee; Nankivell, Matthew Guy; Randon, Giovanni; Kook, Myeong-Cherl; An, Ji Yeong; Grabsch, Heike I.; Prisciandaro, Michele; Nichetti, Federico; Noh, Sung Hoon; Sohn, Tae Sung; Kim, Sung; Wotherspoon, Andrew; Morano, Federica; Cunningham, David; Lee, Jeeyun; Cheong, Jae-Ho; Smyth, Elizabeth Catherine; Pietrantonio, Filippo
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
BMC CANCER
IF3.4
2024-04-085
OAAI
Niger, Monica; Nichetti, Federico; Fornaro, Lorenzo; Pircher, Chiara; Morano, Federica; Palermo, Federica; Rimassa, Lorenza; Pressiani, Tiziana; Berardi, Rossana; Gardini, Andrea Casadei; Sperti, Elisa; Salvatore, Lisa; Melisi, Davide; Bergamo, Francesca; Siena, Salvatore; Mosconi, Stefania; Longarini, Raffaella; Arcangeli, Giuseppina; Corallo, Salvatore; Delliponti, Laura; Tamberi, Stefano; Fea, Elena; Brandi, Giovanni; Rapposelli, Ilario Giovanni; Salati, Massimiliano; Baili, Paolo; Miceli, Rosalba; Ljevar, Silva; Cavallo, Ilaria; Sottotetti, Elisa; Martinetti, Antonia; Busset, Michele Droz Dit; Sposito, Carlo; Di Bartolomeo, Maria; Pietrantonio, Filippo; de Braud, Filippo; Mazzaferro, Vincenzo
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2

二甲双胍联合兰瑞肽治疗晚期胃肠道或肺神经内分泌肿瘤的安全性和抗肿瘤活性: Ib期试验MetNET2

JOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
2023-12-140
OAAI
Pusceddu, Sara; Corti, Francesca; Prinzi, Natalie; Nichetti, Federico; Ljevar, Silva; Busico, Adele; Cascella, Tommaso; Leporati, Rita; Oldani, Simone; Pircher, Chiara Carlotta; Coppa, Jorgelina; Resi, Veronica; Milione, Massimo; Maccauro, Marco; Miceli, Rosalba; Tamborini, Elena; Perrone, Federica; Spreafico, Carlo; Niger, Monica; Morano, Federica; Pietrantonio, Filippo; Seregni, Ettore; Mariani, Luigi; Mazzaferro, Vincenzo; Di Liberti, Giorgia; Fuca, Giovanni; de Braud, Filippo; Vernieri, Claudio
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin
CLINICAL COLORECTAL CANCER
IF3.2
2023-12-013
PRE
Ghelardi, Filippo; Raimondi, Alessandra; Morano, Federica; Randon, Giovanni; Pannone, Alessandra; Guaglio, Marcello; Mazzoli, Giacomo; Nasca, Vincenzo; Milione, Massimo; Leoncini, Giuseppe; Sabella, Giovanna; Greco, Gabriella Francesca; Lampis, Bianca Rosa; Galassi, Margherita; Delfanti, Sara; Nannini, Margherita; Intini, Rossana; Baratti, Dario; Di Bartolomeo, Maria; Deraco, Marcello; Pietrantonio, Filippo
Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations

意大利医学肿瘤学协会关于跨性别和性别多样化人群健康差异的立场文件: 阿西西建议

ECLINICALMEDICINE
IF10
2023-11-017
OAAI
Leone, Alberto Giovanni; Casolino, Raffaella; Trapani, Dario; Miceli, Rosalba; Massagrande, Massimo; Morano, Federica; La Verde, Nicla; Dalu, Davide; Berardi, Rossana; Marsoni, Silvia; Lambertini, Matteo; Iula, Bianca; Carieri, Eva; Converti, Manlio; Di Maio, Massimo; Beretta, Giordano Domenico; Perrone, Francesco; Pietrantonio, Filippo; Cinieri, Saverio

研究方向

暂未获取到该数据
F
Filippo Pietrantonio
H 指数:61论文数:1,034被引数:1.6万
F
Filippo de Braud
H 指数:103论文数:1,561被引数:5.2万
M
Maria Di Bartolomeo
H 指数:61论文数:561被引数:1.6万
S
Sara Lonardi
H 指数:83论文数:1,229被引数:3.4万
C
Chiara Cremolini
H 指数:65论文数:976被引数:2.0万
M
Michele Prisciandaro
H 指数:24论文数:248被引数:2,251
M
Massimo Milione
H 指数:54论文数:456被引数:9,553
A
Alessandra Raimondi
H 指数:28论文数:268被引数:3,038
S
Salvatore Corallo
H 指数:24论文数:222被引数:2,386
M
Monica Niger
H 指数:27论文数:234被引数:2,595